⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRSP News
CRISPR Therapeutics AG
Santhera Appoints Marc Clausse as Chief Commercial Officer to Lead Next Phase of Growth
globenewswire.com
CRSP
REGN
NTLA
EDIT
CAT
Global Telehealth Market is Projected to Cross the USD 2 Trillion Mark by 2034, Driven by Digital Healthcare Transformation | DelveInsight
prnewswire.com
TDOC
CSCO
PHG
IBM
MDT
AMWL
GEHC
HPQ
DOX
ISRG
BMBL
ADMA
FLEX
INTC
GOOG
MSFT
AMZN
NVDA
AAPL
TSLA
JNJ
PFE
ABBV
BMY
MRK
XRAY
SYK
BDX
LULU
ROST
ULTA
COST
MCHP
ON
ADI
TXN
QCOM
AMD
SIRI
CMCSA
VZ
T
MU
AMAT
KLAC
LRCX
WDC
SE
BABA
JD
NTES
PDD
IQ
BIDU
FOX
FOXA
NFLX
DIS
CMG
MCD
SBUX
YUM
CVS
EL
ORCL
CRM
NOW
ADBE
INTU
PAYX
ADP
MA
V
AXP
GS
JPM
BAC
WFC
MS
CME
ICE
SCHW
AMGN
GILD
REGN
BIIB
AZN
NVS
SNY
TEVA
CPRT
ALGN
EXPE
BKNG
MAR
HLT
IHG
WYNN
LVS
MGM
EXAS
ACAD
ALKS
VRTX
CRSP
EDIT
NTLA
NBIX
ALNY
BMRN
IDXX
ZBRA
HON
ETR
NEE
DUK
SO
XOM
CVX
SHEL
GOOGL
META
TMUS
AVGO
MRVL
NXPI
INFY
DELL
HPE
LEN
BRK.B
BRK.A
UNH
CI
CNC
ELV
HCA
EBS
TTWO
EA
NTDOY
SONY
GE
BA
GD
LMT
RTX
NOC
CAT
DE
AGCO
CNH
IRTC
HOLX
TNDM
PODD
RMD
MASI
SNOW
DDOG
PANW
FTNT
CRWD
OKTA
SNPS
CDNS
From Lab Innovation to Life-Saving Therapies: Gene Editing Therapeutics Market Poised to Hit US$ 6.26 Billion by 2032, Expanding at a 147.20% CAGR Driven by Rapid CRISPR Breakthrough: AnalystView Market Insights
globenewswire.com
VRTX
CRSP
Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy
globenewswire.com
CRSP
REGN
PTGX
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
prnewswire.com
BNTX
CRSP
NVCR
IBRX
ONCY
Sickle Cell Disease Competitive Landscape Report 2026: Comprehensive Analysis of Over 40 Companies and More Than 50 Drugs
globenewswire.com
NVS
PFE
AGIO
CRSP
TAK
Longevity Market Report 2026-2036: Advances in AI, Genomics and Regenerative Medicine Are Accelerating Developments
globenewswire.com
VRTX
CRSP
Watchmaker Genomics concede in licenza la proprietà intellettuale CRISPR-Cas9 da Caribou Biosciences per aumentare la produzione e ridurre il costo del sequenziamento per campione
businesswire.com
CRSP
WGO
Watchmaker Genomics concede in licenza la proprietà intellettuale CRISPR-Cas9 da Caribou Biosciences per aumentare la produzione e ridurre il costo del sequenziamento per campione
businesswire.com
CRSP
WGO
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL